$1.22
+0.01 (+0.83%)
Open$1.24
Previous Close$1.21
Day High$1.26
Day Low$1.20
52W High$268.00
52W Low—
Volume—
Avg Volume237.2K
Market Cap4.20M
P/E Ratio—
EPS$-25.66
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 398.2K | 400.3K | 406.3K |
| Net Income | -29,112 | -35,289 | -31,464 |
| Profit Margin | -7.3% | -8.8% | -7.7% |
| EBITDA | -48,158 | -49,842 | -45,919 |
| Free Cash Flow | -34,661 | -49,903 | -42,011 |
| Rev Growth | +16.9% | +4.6% | -8.7% |
| Debt/Equity | 0.13 | 0.15 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.68 | -0.45% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $412.84 | -1.20% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.12 | -0.01% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $508.33 | -1.57% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.64 | -0.29% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $227.29 | +0.07% | 35.2 | 28.41B |